Edoxaban Management in Diagnostic and Therapeutic Procedures (EMIT-AF/VTE) - Trial Design

about

Edoxaban Management in Diagnostic and Therapeutic Procedures (EMIT-AF/VTE) - Trial Design

Item

http://www.wikidata.org/entity/Q56516532

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Edoxaban Management in Diagnostic and Therapeutic Procedures (EMIT-AF/VTE) - Trial Design

@en

Edoxaban Management in Diagnostic and Therapeutic Procedures

@nl

type

Item

label

Edoxaban Management in Diagnostic and Therapeutic Procedures (EMIT-AF/VTE) - Trial Design

@en

Edoxaban Management in Diagnostic and Therapeutic Procedures

@nl

altLabel

Edoxaban Management in Diagnostic and Therapeutic Procedures (EMIT-AF/VTE)-Trial design

@en

prefLabel

Edoxaban Management in Diagnostic and Therapeutic Procedures (EMIT-AF/VTE) - Trial Design

@en

Edoxaban Management in Diagnostic and Therapeutic Procedures

@nl

P1476

Edoxaban Management in Diagnostic and Therapeutic Procedures (EMIT-AF/VTE) - Trial Design

@en

P2093

Amparo Santamaria Ortiz

http://www.w3.org/2001/XMLSchema#string

Martin Unverdorben

http://www.w3.org/2001/XMLSchema#string

Yasuyuki Matsushita

http://www.w3.org/2001/XMLSchema#string

P2860

Edoxaban versus warfarin in patients with atrial fibrillation

Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention o

2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.

Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.

Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures.

Introduction to the ninth edition: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.

Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF.

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients.

Managing new oral anticoagulants in the perioperative and intensive care unit setting.

P304

1123-1129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CLC.23037

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Paolo Colonna

Christian von Heymann

P577

2018-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30069910

http://www.w3.org/2001/XMLSchema#string

P921

diagnosis

medical diagnosis

P932

6221054

http://www.w3.org/2001/XMLSchema#string